Health

Grown Alchemist Completes Change of Ownership

The beauty brand moves to privately held ownership to accelerate growth and drive development in key markets includingNorth America and China HONG KONG, April 2, 2024 /PRNewswire/ -- Grown Alchemist , an award-winning biological beauty brand for the design conscious,...

2024-04-02 16:01 2115

AXA launches IncomeBliss Qualifying Deferred Annuity Policy

Empowering retirement planning with dementia advance benefits and the flexibility to choose between cash payouts or reinvestment of annuities Successful applicants can enjoy exclusive subscription to the 5-Year GoalSaver with up to 4.8% p.a. guaranteed returns upon maturity[1] HONG KONG, April 2...

2024-04-02 15:17 2004

European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers

MONTE CARLO, Monaco, April 2, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), a global pioneer in biotechnology and bioregenerative medicine, is pleased to announce its extraordinary participation in the 22nd Aesthetic & Anti-Ageing Medicine World Congress (AMWC) 2024, which w...

2024-04-02 14:16 2163

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status

ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...

2024-04-02 13:00 2379

Moneymax partners with FWD Life Insurance to empower Filipinos in making better financial decisions

FWD Life Insurance's diverse portfolio of insurance products are now available on Moneymax for easy purchase MANILA, Philippines, April 2, 2024 /PRNewswire/ -- Moneymax, the Philippines' largest personal finance marketplace for financial products and a subsidiary of MoneyHero Limited

2024-04-02 11:54 3423

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

HONG KONG and SHANGHAI, April 2, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended31 December 2023 (the "Reporting Period"). During the R...

2024-04-02 11:31 3498

Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS

Pioneering biologics CDMO rapidly adopts Veeva Vault QMS to advance development and manufacturing operations BANGALORE, India, April 2, 2024 /PRNewswire/ -- Veeva Systems  (NYSE: VEEV) today announced that Kemwell BioPharma, India's largest biologics contract developmen...

2024-04-02 10:30 2128

InsureMO partners with MoneyHero Group to create the premiere digital insurance aggregation and comparison platform in Greater Southeast Asia

SINGAPORE, April 2, 2024 /PRNewswire/ -- InsureMO is thrilled to announce its strategic partnership with MoneyHero Limited (NASDAQ: MNY) to create the premiere digital insurance aggregation and comparison platform inGreater Southeast Asia. InsureMO's cutting-edge middleware platform has been s...

2024-04-02 10:00 3462

Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023

Increase in the number of patients treated and gains in operational efficiency explain record results SÃO PAULO, April 2, 2024 /PRNewswire/ -- Oncoclínicas&Co (B3: ONCO3) – the largest group dedicated to cancer treatment inLatin America – reported a 35.1% growth in its gross revenue in 2023, tot...

2024-04-02 00:38 2152

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of apaper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investigators at theUniversity of Tokyo and the University of Brit...

2024-04-01 21:00 2124

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical characterization step in the candidate dev...

2024-04-01 20:00 2495

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

HONG KONG, April 1, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year endedDecember 31, 2023, along with recent business up...

2024-04-01 19:30 3024

Sixth Appearance at Boao Forum for Asia: Yili Demonstrates Innovative Vigor to the World

BOAO, China, April 1, 2024 /PRNewswire/ -- From March 26th to March 29th, the Boao Forum forAsia is once again underway, with Yili Group being invited for the sixth time to participate in this grand event, showcasing its innovative strength grounded in quality.

2024-04-01 14:06 1964

Elovi Renames to Morinaga Nutritional Foods Vietnam, Fusing Expertise and Technology 'For Better Wellness' in Vietnam

HANOI, Vietnam, April 1, 2024 /PRNewswire/ -- Elovi, a group company of Morinaga Milk Industry (Japan), announces a significant transformation. In a strategic move to further enhance its mission and align with global standards of excellence, Elovi is proud to unveil its new identity asMorinaga Nu...

2024-04-01 12:00 2337

2024 Kaohsiung Smart City Summit & Expo Showcases Latest Digital and Net-Zero Transformation Technologies

KAOHSIUNG, April 1, 2024 /PRNewswire/ -- The 2024 Kaohsiung Smart City Summit & Expo(KSCSE), held at the Kaohsiung Exhibition Center, concluded perfectly. Over the course of the 3-day exhibition, it attracted more than 40,000 visitors. There were a total of 150 exhibitors, 550 booths, and 6 main ...

2024-04-01 10:57 829

IMM CAREHUB - REDEFINING HEALTHY AGEING AND GERIATRIC REHABILITATION IN ASIA

KUALA LUMPUR, Malaysia, April 1, 2024 /PRNewswire/ --IMM Carehub, a pioneer in preventive care, healthy ageing, and geriatric rehabilitation, continues to make waves in the healthcare industry. AsMalaysia's First Lifestyle Rehab Centre for Seniors, IMM Carehub stands as a beacon of innovation and...

2024-04-01 09:00 1639

Hyosung TNC Invests $1 Billion in Future "Bio" Business

* Hyosung TNC to establish a new Bio-BDO (Butanediol) 50,000 ton factory in Vietnam with plans to expand future plants to an annual output of 200,000 tons  * Replacing fossil raw materials with those from sugarcane, entering the bio raw material market  * Applications across various industri...

2024-04-01 08:18 2105

CAIR-HK AI & Robotics Forum for Healthcare: Spotlight Interdisciplinary Integration of AI and Medicine

HONG KONG, March 29, 2024 /PRNewswire/ -- In this data-driven era, artificial intelligence and robotics technologies are rapidly reshaping people's lifestyles, with their profound impact in the field of medicine and healthcare becoming increasingly evident. From image-assisted diagnosis to intell...

2024-03-29 23:00 3554

Aohua receives Endoscopy Award at Healthcare Asia Medtech Awards 2024

SINGAPORE, March 29, 2024 /PRNewswire/ -- At the most recent Healthcare Asia Medtech Awards 2024, Aohua Endoscopy, a medical equipment manufacturer, won the Endoscopy Product Innovation Award for creating the Aohua4K AQ-300 video endoscopy system, which provides a better endoscopic diagnosis and ...

2024-03-29 21:00 3798

Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights

SUZHOU, China, March 29, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year endedDecember 31, 2023 and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, "In 2023, Alphamab Onc...

2024-03-29 10:42 8282
1 ... 65666768697071 ... 580

Week's Top Stories